PHR1680
地氯雷他定
Pharmaceutical Secondary Standard; Certified Reference Material
同義詞:
地氯雷他定, 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H- benzo[5,6]cyclohepta[1,2,b]pyridine, Clarinex®
登入查看組織和合約定價
全部照片(1)
About This Item
經驗公式(希爾表示法):
C19H19ClN2
CAS號碼:
分子量::
310.82
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24
推薦產品
等級
certified reference material
pharmaceutical secondary standard
品質等級
agency
traceable to Ph. Eur. Y0001584
traceable to USP 1173042
API 家族
desloratidine
CofA
current certificate can be downloaded
包裝
pkg of 1 g
技術
HPLC: suitable
gas chromatography (GC): suitable
應用
pharmaceutical (small molecule)
形式
neat
儲存溫度
2-30°C
SMILES 字串
Clc1ccc2c(CCc3cccnc3\C2=C4\CCNCC4)c1
InChI
1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2
InChI 密鑰
JAUOIFJMECXRGI-UHFFFAOYSA-N
基因資訊
human ... HRH1(3269)
尋找類似的產品? 前往 產品比較指南
相關類別
一般說明
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Desloratadine is one of the orally active, highly selective peripheral H1 receptor antagonists that does not exert any significant effect on the central and autonomic nervous systems. The potency of desloratadine is more than that of loratadine and it exhibits substantial overall pharmacological profile.
Desloratadine is one of the orally active, highly selective peripheral H1 receptor antagonists that does not exert any significant effect on the central and autonomic nervous systems. The potency of desloratadine is more than that of loratadine and it exhibits substantial overall pharmacological profile.
應用
Desloratadine may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations and plasma samples by various chromatography techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
生化/生理作用
A non-sedating H1-receptor antagonist, free from antimuscarinic/anticholinergic effects. It has novel antiallergic and anti-inflammatory effects.
Desloratadine is a selective and nonsedating histamine H1 receptor antagonist, an active metabolite of loratadine (Claritin), used to relieve hay fever and allergy symptoms with less drowsiness than other antihistamines; does not significantly inhibits cardiac K+ channels at clinically achievable blood levels. Free from antimuscarinic/anticholinergic effects.
分析報告
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他說明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
腳註
To see an example of a Certificate of Analysis for this material enter LRAC2775 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
推薦產品
Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
法律資訊
Clarinex is a registered trademark of Schering Corp.
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 1
閃點(°F)
390.2 °F - Pensky-Martens closed cup
閃點(°C)
199 °C - Pensky-Martens closed cup
客戶也查看了
Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma.
El-Enany N, et al.
Chemical & Pharmaceutical Bulletin, 55(12), 1662-1670 (2007)
High-performance liquid chromatographic method for the bioequivalence evaluation of desloratadine fumarate tablets in dogs.
Liu L, et al.
Journal of Pharmaceutical and Biomedical Analysis, 34(5), 1013-1019 (2004)
A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms.
Rao DD, et al.
Journal of Pharmaceutical and Biomedical Analysis, 51(3), 736-742 (2010)
Determination of desloratadine in drug substance and pharmaceutical preparations by liquid chromatography.
Qi M, et al.
Journal of Pharmaceutical and Biomedical Analysis, 38(2), 355-359 (2005)
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務